FSANZ Approves New Heart Health Claim condition for Isolated Soy Protein

Food Standards Australia New Zealand (FSANZ) has approved a new heart health claim for isolated soy protein, enabling food and beverage manufacturers to link its consumption with improved blood cholesterol levels. The decision marks a significant regulatory development for functional and plant-based nutrition products sold across Australia, New Zealand.
Under the approved conditions, the authorised claim states:
Consuming 2025 g of isolated soybean protein from foods or beverages daily, as part of a healthy, balanced diet, contributes to heart health by supporting healthy cholesterol levels.
This claim allows manufacturers to clearly communicate the cardiovascular benefits of isolated soy protein when used at effective intake levels.
Isolated soy protein is derived from soybeans and contains approximately 90 per cent protein, making it a high-quality, complete protein that delivers all nine essential amino acids in amounts required by both children and adults. Due to its strong nutritional profile and versatility, isolated soy protein is widely used to enhance the nutritional value of a broad range of food and beverage products.
Common applications include nutrition bars, breakfast cereals, baked goods, meat alternatives, and fortified plant-based milks. According to FSANZ-approved guidance, consumers can achieve the recommended 2025 g daily intake through one to two servings of soy-based foods, such as a soy protein bar providing around 17 g of protein, or a soy-based beverage delivering 1520 g of protein per serving.
The approval aligns with growing consumer interest in plant-based proteins and heart-friendly dietary options, and provides regulatory clarity for manufacturers seeking to innovate within the functional food space. By formally recognising the cholesterol-supporting role of isolated soy protein, FSANZ has strengthened the scientific and regulatory framework supporting soy-based products in the region.Industry stakeholders note that the claim is expected to encourage further product development and wider adoption of soy protein in everyday foods, particularly in the context of diets aimed at improving cardiovascular health.